103 related articles for article (PubMed ID: 7286887)
1. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S
Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
3. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
[TBL] [Abstract][Full Text] [Related]
4. Nomifensine in the diagnosis of hyperprolactinemia.
Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
[TBL] [Abstract][Full Text] [Related]
5. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
6. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
8. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
[No Abstract] [Full Text] [Related]
9. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
10. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
[No Abstract] [Full Text] [Related]
11. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.
Pontiroli AE; Falsetti L
Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360
[TBL] [Abstract][Full Text] [Related]
12. The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma.
Jeske W; Stopińska U
Endokrynol Pol; 1981; 32(1):17-24. PubMed ID: 7250073
[No Abstract] [Full Text] [Related]
13. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
Canales ES; Cano C; Ablanedo J; Zárate A
Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
[TBL] [Abstract][Full Text] [Related]
14. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
15. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
[TBL] [Abstract][Full Text] [Related]
16. A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test.
Genazzani AR; Camanni F; Massara F; Picciolini E; Cocchi D; Belforte L; Müller EE
Acta Endocrinol (Copenh); 1980 Feb; 93(2):139-48. PubMed ID: 6769270
[No Abstract] [Full Text] [Related]
17. Biochemical diagnosis of prolactinoma.
Müller EE; Genazzani A; Camanni F; Massara F; Molinatti GM; Cocchi D
Lancet; 1979 Aug; 2(8136):257. PubMed ID: 89375
[No Abstract] [Full Text] [Related]
18. [Prolactin-secreting pituitary gland adenoma. Present-day possibilities of diagnosis and treatment].
Basso A; Guitelman A; Amezua L; Molocznik I; Mancini A; Montez M
Neurochirurgie; 1975; 21(2):111-20. PubMed ID: 1105224
[TBL] [Abstract][Full Text] [Related]
19. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
Genazzani AR; De Leo V; Camanni F; Müller EE
J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
[No Abstract] [Full Text] [Related]
20. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
